A Pilot Study of Oxalate Absorption in Secondary Hyperoxaluria
Summary
The lay summary the sponsor registered on ClinicalTrials.gov.
Investigators
The overall officials registered on this study. Names that resolve to a FindMyKOL profile link to it; the rest are shown as registered.
- Annamaria Kausz, MD, MS
Allena Pharmaceuticals
Study Director
A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.
Sites
5 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.
- Urological Associates of Southern Arizona, Pc
Tucson, Arizona, United States
- Applied Research Center of Arkansas, Inc.
Little Rock, Arkansas, United States
- Regional Urology, Llc
Shreveport, Louisiana, United States
- Omega Medical Research
Warwick, Rhode Island, United States
- Urology of Virginia
Virginia Beach, Virginia, United States
Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.
Drugs studied
No drug or biological interventions are in our data for this study. It may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →
Registration & key dates
Registry attributes as recorded on the ClinicalTrials.gov study record.
- Start
- 30 Nov 2016
- Primary completion
- 31 Jan 2017
- Completion
- 31 Mar 2017
- Last update posted
- 28 Oct 2021
- Registered enrollment
- 22
- Registry id
- NCT03095885
Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 4 Nov 2026. Registry facts are shown as registered by the study sponsor; FindMyKOL does not interpret them.